Trillium Asset Management LLC increased its stake in shares of Cigna Corp (NYSE:CI) by 0.1% during the 1st quarter, HoldingsChannel reports. The fund owned 128,814 shares of the health services provider’s stock after purchasing an additional 154 shares during the quarter. Cigna comprises about 1.0% of Trillium Asset Management LLC’s portfolio, making the stock its 28th biggest position. Trillium Asset Management LLC’s holdings in Cigna were worth $20,716,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in the stock. 1 North Wealth Services LLC acquired a new position in Cigna in the fourth quarter valued at $25,000. Clarfeld Financial Advisors LLC acquired a new position in shares of Cigna during the fourth quarter worth about $25,000. Private Ocean LLC acquired a new position in shares of Cigna during the fourth quarter worth about $26,000. Delta Asset Management LLC TN acquired a new position in shares of Cigna during the fourth quarter worth about $28,000. Finally, Litman Gregory Asset Management LLC acquired a new position in shares of Cigna during the fourth quarter worth about $30,000. Hedge funds and other institutional investors own 88.61% of the company’s stock.
Shares of NYSE CI traded down $3.09 on Wednesday, hitting $152.20. The company’s stock had a trading volume of 10,390 shares, compared to its average volume of 3,328,440. Cigna Corp has a 12-month low of $141.95 and a 12-month high of $226.60. The company has a market capitalization of $58.93 billion, a PE ratio of 10.78, a price-to-earnings-growth ratio of 0.78 and a beta of 0.69. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.70 and a quick ratio of 0.70.
CI has been the topic of a number of research analyst reports. ValuEngine raised shares of Cigna from a “strong sell” rating to a “sell” rating in a report on Thursday, April 25th. Morgan Stanley decreased their price objective on shares of Cigna from $304.00 to $299.00 and set an “overweight” rating on the stock in a report on Tuesday, February 5th. Goldman Sachs Group reissued a “buy” rating on shares of Cigna in a report on Saturday, February 2nd. Zacks Investment Research downgraded shares of Cigna from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 20th. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $245.00 price objective on shares of Cigna in a report on Sunday, April 21st. One research analyst has rated the stock with a sell rating, two have given a hold rating and fifteen have assigned a buy rating to the company. Cigna presently has a consensus rating of “Buy” and a consensus price target of $225.85.
In other news, Director William D. Zollars sold 272 shares of the business’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $168.43, for a total value of $45,812.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brian C. Evanko acquired 2,000 shares of the business’s stock in a transaction dated Monday, March 11th. The stock was purchased at an average cost of $163.40 per share, with a total value of $326,800.00. The disclosure for this purchase can be found here. Insiders own 0.80% of the company’s stock.
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Featured Story: Return on Equity (ROE)
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.